Krebs Biochemicals and Industries informs about post offer status

30 Nov 2015 Evaluate

Arihant Capital Markets (‘Manager to the Offer’) on behalf of Ipca Laboratories (‘Acquirer’) has informed about this Post Offer Public Announcement to the shareholders of Krebs Biochemicals and Industries (‘Target Company’), pursuant to Regulation 18 (12) of the Securities and Exchange Board of India (Substantial Acquisition of Shares and Takeovers) Regulations 2011, as amended (SEBI SAST Regulations) In respect of Open Offer to acquire up to 35,73,515 Equity Shares, constituting 26% of the fully diluted voting Equity Share Capital (the ‘Offer’) of Target Company. The Detailed Public Statement (‘DPS) with respect to the aforementioned Offer was published on February 24, 2015.

The above information is a part of company’s filings submitted to BSE.

Krebs Biochem.&Inds Share Price

74.10 -1.31 (-1.74%)
30-Apr-2025 16:59 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1830.20
Dr. Reddys Lab 1183.00
Cipla 1549.65
Lupin 2094.65
Zydus Lifesciences 887.70
View more..
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
×
Please wait your portfolio is updating...